key: cord-0949349-p01knfxl
authors: Hippen, Benjamin E.; Axelrod, David A.; Maher, Kennan; Li, Ruixin; Kumar, Deepali; Caliskan, Yasar; Alhamad, Tarek; Schnitzler, Mark; Lentine, Krista L.
title: Survey of current transplant center practices regarding COVID‐19 vaccine mandates in the United States
date: 2022-03-01
journal: Am J Transplant
DOI: 10.1111/ajt.16995
sha: 8f32b0ea4441c100af578ab7efad11287cf65f02
doc_id: 949349
cord_uid: p01knfxl

An electronic survey canvassing current policies of transplant centers regarding a COVID‐19 vaccine mandate for transplant candidates and living donors was distributed to clinicians at US solid organ transplant centers performing transplants from October 14, 2021–November 15, 2021. Responses were received from staff at 141 unique transplant centers. These respondents represented 56.4% of US transplant centers, and responding centers performed 78.5% of kidney transplants and 82.4% of liver transplants in the year prior to survey administration. Only 35.7% of centers reported implementing a vaccine mandate, while 60.7% reported that vaccination was not required. A minority (42%) of responding centers with a vaccine mandate for transplant candidates also mandated vaccination for living organ donors. Centers with a vaccine mandate most frequently cited clinical evidence supporting the efficacy of pre‐transplant vaccination (82%) and stewardship obligations to ensure organs were transplanted into the lowest risk patients (64%). Centers without a vaccine mandate cited a variety of reasons including administrative, equity, and legal considerations for their decision. Transplant centers in the United States exhibit significant heterogeneity in COVID‐19 vaccination mandate policies for transplant candidates. While all centers encourage vaccination, most centers have not mandated COVID‐19 vaccination for candidates and living donors, citing administrative opposition, legal prohibitions, and concern about equity in access to transplants.

The survey instrument was developed by the study investigators (Table S1 ). The authors constructed several of the survey questions to address ethical concerns raised in a recent review. 7 The final survey instrument asked for respondents' center (for response rate computation and aggregation), role at the center, and vaccination policies for transplant candidates, caretakers, and co-habitants. For centers without a mandate, reasons for not instituting a mandate were examined using non-exclusive, nonranked choices. For centers with a vaccine mandate, the scope of a mandate was assessed across several hypothetical scenarios.

Centers with and without a mandate for active candidates were also queried regarding vaccination requirements for living donors.

Informed consent was obtained through the online "cover page" of the survey, which the surveyed acknowledged by clicking a box at the bottom of the cover page. This survey study was approved by the Saint Louis University Institutional Review Board (IRB protocol #32292). 

Each transplant center was represented once in the primary analysis. Representative responses from centers with multiple respondents were selected using a hierarchical algorithm, prioritizing responses from transplant surgeons, transplant physicians, and other providers, similar to previous methods. [9] [10] [11] [12] [13] For centers with more than one response from a respondent in the same role at the same transplant center, after the above two steps, we retained the earliest submitted survey ( Figure S1 ). The volume of All responses from transplant providers were categorized by transplant center role and summarized in a secondary analysis.

Responses to each survey question were reported with frequencies and percentages. To obtain percentages, we divided the number of center responses (i.e., row totals) by the total number of centers that responded to the question, such percentages reflect the proportions of respondents. For questions where participants were asked to "select all that apply," the denominator for calculating percentages was the total number of participants responding to that question. For these questions, as one respondent could choose more than one option, column totals may exceed 100%. Respondents selecting "Other" were allowed to enter free-text responses. Analyses were performed using SAS version 9.4.

To assess whether there was a correlation between the presence or absence of a vaccine mandate with prevalent COVID-19 vaccination rates, we cross-referenced survey data with publicly available state-level data on point prevalent COVID-19 vaccination rates on October 27, 2021. 14 To address the problem of dynamic changes in the rates of vaccination over time, we chose vaccination rates reported on a single date during the administration of the survey. We stratified US states into tertiles by percent of population vaccinated: Group 1 with a vaccination rate of 41%-50%; Group 2 with a vaccination rate of 51%-60%; Group 3 with a vaccination rate of 61%-71% (Table S2 ).

We received 298 survey responses from US solid organ transplant centers, of which 22.8% were from a center with only one survey respondent and 77.1% were from centers with more than one respondent. After limiting to unique center responses, 141 center responses were available for primary analyses ( Figure S1 ). Respondents represented 56.4% of US transplant centers. Responding centers performed 78.5% of kidney transplants and 82.4% of liver transplants in the year prior to survey administration. Participants represented diverse geographies of practice across the country (Table 1 ).

Among responding centers, 60.7% had not instituted a policy mandating vaccination for all patients as a requirement for active transplant listing ( Table 2 ). Among those centers that had not instituted a vaccine mandate policy, the most frequently cited reasons included:

concerns that a mandate may exacerbate inequities in access to transplantation (41%), would result in undue pressure on transplant candidates (32%), and could result in legal consequences for the center (34%) ( Figure 1A) . No center without a vaccine mandate for transplant candidates imposed a vaccine mandate for living donors.

We found that 35.7% of centers had instituted a policy mandating vaccination as a requirement for active transplant candidacy ( Table 2) .

Among those centers instituting a vaccine mandate policy, the most frequent justification included: public health-based obligations (52%), stewardship obligations to ensure organs are transplanted into patients at the lowest risk for SARS-CoV-2 infection (64%), and the need to reduce transmission risks to healthcare personnel (40%), other patients, and family members (40%) ( Figure 1B ). At the time of our survey, most centers with a vaccine mandate in place did not require booster doses for candidates. Nearly all centers (95%) with a mandate did not require clinical evidence demonstrating vaccine responsiveness (e.g., measurement of anti-SARS-CoV-2 spike protein antibodies). Few centers extended a vaccine requirement to a candidate's support person (10%) or cohabitants (5%). In the case of religious objections to the vaccine, 45% of centers with a mandate reported they would decline these patients for active candidacy, while the remainder would either agree to an exemption (17%) or some version of a case-by-case consideration (38%) ( Other (please specify) 3 (7) If your center has instituted a COVID−19 vaccine mandate for adult or pediatric transplant candidates, and your candidate regularly cohabitates with others (family or otherwise), does your center also require that the candidate's cohabitants be vaccinated against COVID−19? (n = 40) n (%) 

COVID-19-associated mortality among kidney transplant recipients and candidates in the United States

COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes -an ELITA/ELTR multicentre cohort study

Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

Statement about Vaccine Efficacy in Organ Transplant Recipients

ASTS Position on COVID-19 Vaccine and Transplant Patients

Organ Centers to Transplant Patients: Get a Covid Vaccine or Move down on Waitlist

The limits of refusal: an ethical review of solid organ transplantation and vaccine hesitancy

Operational challenges in the COVID era: asymptomatic infections and vaccination timing

Transplant clinician opinions on use of race in the estimation of glomerular filtration rate

Care of international living kidney donor candidates in the United States: A survey of contemporary experience, practice, and challenges

Survey of clinician opinions on kidney transplantation from hepatitis C virus positive donors: identifying and overcoming barriers

Survey of US living kidney donation and transplantation practices in the COVID-19 era

Kidney recipients with allograft failure, transition of kidney care (KRAFT): a survey of contemporary practices of transplant providers

The New York Times. See How Vaccinations Are Going in Your County and State

The Red/Blue Divide in COVID-19 Vaccination Rates

More organ transplant centers require patients to get COVID-19 vaccine, or get bumped down waitlist

Hospital system says it will deny trnasplants to the unvaccinated in 'almost all situations

Mandating COVID-19 vaccination prior to kidney transplantation in the United States: no solutions, only decisions

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy

High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients

Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls

COVID-19 vaccine acceptance and beliefs among black and hispanic Americans

Association of racial disparities with access to kidney transplant after the implementation of the new kidney allocation System

Association of race and ethnicity with live donor kidney transplantation in the United States From

Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system

Failure to advance access to kidney transplantation over two decades in the United States

Fall 2021: The Great Vaccination Dilemma

Congressional Research Service. COVID-19 Liability: Tort, Workplace Safety, and Securities Law

State Efforts to Ban or Enforce COVID-19 Vaccine Mandates and Passports

United Network for Organ Sharing (UNOS)

Consulting fee: CareDx, Sanofi. Speaker: Sanofi. Equity: CareDx.Financial support from the Mid-America Transplant endowed chair in transplantation.